Stock Rating Downgrade
Of late the Value Trend Rating for Integra LifeSciences Holdings Co (NASDAQ: IART) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential.
Recent Price Action
Integra LifeSciences Holdings Co (NASDAQ: IART) stock declined modestly by -1.3% on 3/18/24. The stock closed at $34.24. This decline was accompanied by normal trading volume. The stock has performed in line with the market over the last nine months and has declined -6.8% during the last week.
Current PriceTarget Research Rating
IART is expected to continue to be an important Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Integra LifeSciences Holdings has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Integra LifeSciences Holdings has a neutral Appreciation Score of 54 and a slightly negative Power Rating of 33, leading to the Negative Value Trend Rating.
Be the first to comment